Unfortunately, your browser is too old to work on this website. Please upgrade your browser
27 November 2020

Government formally asks MHRA to evaluate the Oxford/AstraZeneca vaccine for authorisation

Summary

The government formally requests the Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate the Oxford/AstraZeneca vaccine for temporary supply. Health and Social Care Secretary Matt Hancock says this will help ‘understand the data and determine whether it meets rigorous safety standards’, a significant step towards getting the vaccine approved and deployed.

Initial data demonstrate ‘at least 70%’ effectiveness against COVID-19 when two full doses are given. This increases to 90% when a half-dose is administered initially and followed by a full dose. The UK government secured 100 million doses of the Oxford/AstraZeneca vaccine following a deal on 23 November 2020. Pending MHRA authorisation, the government expects to receive up to 4 million doses by the end of 2020 and 40 million by the end of March 2021.

Source(s)

Gov.uk press release